⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20246274 | 0.84 | — | — | |
| SCHEMBL20246241 | 0.84 | — | — | |
| SCHEMBL15137978 | 0.84 | — | — | |
| SCHEMBL22279615 | 0.79 | — | — | |
| SCHEMBL1956196 | 0.74 | — | — | |
| SCHEMBL1956200 | 0.74 | — | — | |
| SCHEMBL1956198 | 0.74 | — | — | |
| SCHEMBL12551024 | 0.72 | CYP11B2 (0.33) | — | |
| SCHEMBL29114031 | 0.72 | — | — | |
| SCHEMBL697501 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122051368-A | Preparation method of gel electrolyte, quasi-solid lithium ion battery containing gel electrolyte and application of quasi-solid lithium ion battery | 江苏国轩新能源科技有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20260049062-A1 | SARS-COV-2 INHIBITORS FOR TREATING CORONAVIRUS INFECTIONS | INSILICO MEDICINE IP LTD (CN) | 2026-02-19 | — | — | US | disclosed |
| CN-121260927-A | Lithium ion battery electrolyte and application thereof | 远景动力技术(江苏)有限公司 | 2026-01-02 | — | — | CN | disclosed |
| EP-4622968-A1 | HETEROCYCLIC COMPOUNDS, PREPARATION METHODS AND USES THEREOF | InventisBio Co., Ltd. (CN) | 2025-10-01 | — | — | EP | disclosed |
| CN-115803322-B | SARS-COV-2 inhibitors with covalent modifications for treatment of coronavirus infection | 英矽智能科技知识产权有限公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-113382767-B | Urea compounds having substituents | 第一三共株式会社 | 2024-12-24 | — | — | CN | disclosed |
| EP-4426682-A1 | SARS-COV-2 INHIBITORS FOR TREATING CORONAVIRUS INFECTIONS | Insilico Medicine IP Limited (HK) | 2024-09-11 | — | — | EP | disclosed |
| CN-118510759-A | SARS-COV-2 inhibitors for treatment of coronavirus infection | 英矽智能科技知识产权有限公司 | 2024-08-16 | — | — | CN | disclosed |
| WO-2024109923-A1 | HETEROCYCLIC COMPOUNDS, PREPARATION METHODS AND USES THEREOF | InventisBio Co., Ltd. (CN) | 2024-05-30 | — | — | WO | disclosed |
| US-20240025860-A1 | SARS-COV-2 INHIBITORS FOR TREATING CORONAVIRUS INFECTIONS | INSILICO MEDICINE IP LIMITED (HK) | 2024-01-25 | — | — | US | disclosed |
| WO-2013107405-A1 | THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE | AGIOS PHARMACEUTICALS, INC. (US) | 2013-07-25 | — | — | WO | disclosed |
| WO-2013107291-A1 | THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE | AGIOS PHARMACEUTICALS, INC. (US) | 2013-07-25 | — | — | WO | disclosed |
| US-20130184222-A1 | THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USE | AGIOS PHARMACEUTICALS, INC (US) | 2013-07-18 | — | — | US | disclosed |
| CN-101233098-A | Process for the preparation of geminal ((difluorocycloalkyl) methyl) amines | ASTRAZENECA AB (SE) | 2008-07-30 | — | — | CN | disclosed |
| US-20080167488-A1 | Process for the Preparation of Geminal ((Difluorocycloalkyl)Methyl) Amines | ASTRAZENECA AB (SE) | 2008-07-10 | — | — | US | disclosed |
| US-20080167488-A1 | Process for the Preparation of Geminal ((Difluorocycloalkyl)Methyl) Amines | ASTRAZENECA AB (SE) | 2008-07-10 | — | — | US | disclosed |
| US-20080167488-A1 | Process for the Preparation of Geminal ((Difluorocycloalkyl)Methyl) Amines | ASTRAZENECA AB (SE) | 2008-07-10 | — | — | US | disclosed |
| EP-1912930-A1 | PROCESS FOR THE PREPARATION OF GEMINAL ((DIFLUOROCYCLOALKYL)METHYL) AMINES. | AstraZeneca AB (SE) | 2008-04-23 | — | — | EP | disclosed |
| WO-2007013848-A1 | PROCESS FOR THE PREPARATION OF GEMINAL ((DIFLUOROCYCLOALKYL)METHYL) AMINES. | ASTRAZENECA AB (SE) | 2007-02-01 | — | — | WO | disclosed |
| WO-2007013848-A1 | PROCESS FOR THE PREPARATION OF GEMINAL ((DIFLUOROCYCLOALKYL)METHYL) AMINES. | ASTRAZENECA AB (SE) | 2007-02-01 | — | — | WO | disclosed |